RedHill Biopharma Ltd. ADR (RDHL)
Market Closed
18 Sep, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 57
-0.02
-4.2158%
$
1.73M Market Cap
- P/E Ratio
- Div Yield
81,000 Volume
- Eps
$ 0.59
Previous Close Want to track RDHL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Israel-Based RedHill's Investigational COVID-19 Treatment Shows Encouraging Action In Obesity And Diabetes
On Monday, RedHill Biopharma Ltd. RDHL released results from multiple in vivo studies, undertaken by RedHill's partner, Apogee Biotechnology Corporation.
Benzinga | 2 years ago
Why Is RedHill Biopharma (RDHL) Stock Up 75% Today?
One of today's biggest movers in the biotech sector is RedHill Biopharma (NASDAQ: RDHL ), a little-known specialty player in the space focusing on gastrointestinal and infectious diseases. Today, RDHL stock is up more than 75% in early afternoon trading on an announcement from the company that it has seen positive results for a key Phase 3 study.
Investorplace | 2 years ago
